MarketsStocksJAGSNPHARM
JA

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARMBSE: 507789Healthcare
Download Research Report7-page PDF
197.50
-2.73%
NSE · auto-updates while market open
Prev Close
₹231.51
Day High
₹207.15
Day Low
₹197.25
Mkt Cap
₹267 Cr
P / E
6.2
P / B
1.0
ROE
16.7%
52W High
₹301.65
52W Low
₹155.00
Key Metrics
Market Cap
₹267 Cr
P / E
6.20
P / B
0.96
EV / EBITDA
2.96
ROCE
22.7%
ROE
16.7%
Debt / Equity
0.00
Book Value
₹206.21
EPS
₹6.40
Div Yield
1.2%
Face Value
-
Promoter Holding
67.9%
Revenue · ₹ Cr
159
FY20
188
FY21
226
FY22
237
FY23
209
FY24
269
FY25
287
FY26
Net Profit · ₹ Cr
8
FY20
17
FY21
20
FY22
27
FY23
22
FY24
55
FY25
43
FY26
EPS · ₹ per share
₹3.0
FY20
₹6.5
FY21
₹7.5
FY22
₹10.2
FY23
₹8.5
FY24
₹8.3
FY25
₹6.4
FY26
P / E Ratio · price ÷ TTM EPS
31426371470-1Jun 21Feb 23Oct 24Jun 26
P/E 31.0×Median 17.7×TTM EPS
Q1 2026 snapshot
Sales
₹67 Cr
Operating profit
-
OPM
-
Net profit
₹9 Cr
EPS
₹1.25
Scorecard · 7 axes
Quality
Strong
92/100
Valuation
Strong
6.2×
Growth
Good
+14.0%
Profitability
Good
19.7%
Performance
Bad
-13.2%
Entry Point
Good
65%
Red Flags
Strong
0 flags
Shareholding Pattern
67.9%Promoter
Promoter67.9%
FII2.4%
DII0.2%
Public29.4%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue74.02561.3378.4477.4975.9267.37
Net Profit31.996.58310.79512.57410.9518.762
NPM %43.2%10.7%13.8%16.2%14.4%13.0%
AlertPre-trade